Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
773.740.05%
QQQ
748.320.12%
BTC/USD
86261.640.0738%
DIA
517.870.02%
GLD
400.06-
TLT
81.780.04%

Caribou Biosciences Inc (CRBU) Stock Price, Quote, News & History

CRBUNASDAQ
Trade with Public
Trade with Public
$1.34
0.043.08%
At close: Sep 22, 5:00 PM EST
$1.35
0.010.75%
After Hours: 7:44 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Caribou Biosciences (CRBU) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
$1.32
Close
$1.34
Volume / Avg.
1.22M / 1.64M
Day Range
$1.31 - $1.36
52 Wk Range
1.25 - 3.54
Market Cap
$144.73M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
40
Short Interest
12.1%
Days to Cover
12.94

Recent Caribou Biosciences, Inc. News

Why Is CRISPR Genome-Editing Firm Caribou Biosciences Stock Trading Higher Today>

Caribou Biosciences shares rose after its CAR-T therapies showed high response rates and durable remissions in lymphoma and myeloma trials.
Vandana Singh

Why Lucas GC Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

FDA Halts Trials Exporting Americans' Cells To Hostile Countries For Genetic Engineering

FDA launches review of trials that sent American DNA to China without full consent; NIH investigates impact of Biden-era exemption on federally funded research
Vandana Singh

Attention Biotech Investors - Stocks To Watch From RBC Global Healthcare Conference

RBC's Chris McCarthy discusses biotech investor sentiment at the RBC Global Healthcare Conference. Focused on upcoming binary catalysts, McCarthy highlights Agios Pharmaceuticals, Caribou Biosciences, and Corbus Pharmaceuticals with key 2024 data readouts and trials.
Vandana Singh

Kura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining by around 100 points on Friday.
Avi Kapoor

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-95.78M
Investing Cash Flow (TTM)
71.75M
Financing Cash Flow (TTM)
24.98M
Free Cash Flow (TTM)
-95.75M
Capital Expenditure (TTM)
28.00K
Net Change in Cash (TTM)
947.00K

Analyst Trends and Forecast

1
Apr
1
May
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$53.71M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
12.11
PB Ratio (TTM)
1.42
Earnings Yield % (TTM)
-83.08%
Earnings Yield % (FWD)
-99.23%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.92

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$26.19M
Debt to Equity
0.27
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$1.32
Close
$1.34
Volume / Avg.
1.22M / 1.64M
Day Range
$1.31 - $1.36
52 Wk Range
1.25 - 3.54
Market Cap
$144.73M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
40
Short Interest
12.1%
Days to Cover
12.94

About

Sector
Health Care
Industry
Biotechnology
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The compa...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Caribou Biosciences (CRBU) stock?

A

You can purchase shares of Caribou Biosciences (NASDAQ:CRBU) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Caribou Biosciences (CRBU) competitors?

Q

What is the forecast, or price target, for Caribou Biosciences (CRBU) stock?

A

Caribou Biosciences has a consensus price target of $11.86.

Q

What is the current price for Caribou Biosciences (CRBU)?

A

The stock price for Caribou Biosciences (NASDAQ: CRBU) is $1.35 last updated September 22, 2026 at 7:44 PM EDT.

Q

Does Caribou Biosciences (CRBU) pay a dividend?

A

There are no upcoming dividends for Caribou Biosciences.

Q

When is Caribou Biosciences (NASDAQ:CRBU) reporting earnings?

A

Caribou Biosciences does not have any upcoming earnings scheduled.

Q

Is Caribou Biosciences (CRBU) going to split?

A

There is no upcoming split for Caribou Biosciences.

Q

What sector and industry does Caribou Biosciences (CRBU) operate in?

A

Caribou Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved